Pharmaceutical: Stay order set aside against deregulation of nonessential drugs – By Taurus Research
<p></p><ul><li><span style="font-family:Arial, Helvetica, sans-serif;font-size:medium;">On February 6th, 2024, the Interim Government granted
approval for the deregulation of non-essential drugs, thereby exempting them
from the Drug Act of 1976 and calling for amendments to the Drug Act Policy of
2018. Nonetheless, a petition filed in the Lahore High Court led to a stay
order being issued against the deregulation.</span></li></ul><ul><li><span style="font-family:Arial, Helvetica, sans-serif;font-size:medium;">According to the 2018 Drug Policy, drugs are categorized
into essential and non-essential, with government-regulated prices linked to
CPI of the immediately preceding financial year at rates of 70% increase in CPI
(with a cap of 7%) for essential and 100% increase in CPI (with a cap of 10%)
for non-essential drugs. Additional...
